Ryu Kanzaki

16PUBLICATIONS
19CO-AUTHORS
Solid tumoursPredictive and prognostic markersAnaesthesiologyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 15, 2026
Treatment strategies and outcomes in patients with synchronous multiple primary malignancies involving lung cancer.

|Sep 08, 2024
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma.

Ryu Kanzaki, Steven Reid, Paulina Bolivar

|Apr 22, 2024
Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.

Ryu Kanzaki, Hiroyuki Fukuda, Masao Kobayashi

|Mar 01, 2024
Outcomes and prognostic factors of repeat pulmonary metastasectomy.

Ryu Kanzaki, Hirokazu Watari, Akiisa Omura

|May 31, 2022
Utility of the surgical Apgar score for predicting the short- and long-term outcomes in non-small-cell lung cancer patients who undergo surgery.

Akihiro Nagoya, Ryu Kanzaki, Kenji Kimura

|Jul 06, 2021
CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.

Shan Wang, Emelie Englund, Pontus Kjellman

Pageof 3

Frequent Collaborators

2 joint publications

Shan Wang

2 joint publications

Emelie Englund

2 joint publications

Zhen Li

2 joint publications

Johannes Kumra Ahnlide